Latest debt-to-equity ratio

Kyverna Therapeutics Debt-to-equity ratio

Direct answer

Kyverna Therapeutics's debt-to-equity ratio is 19.93%.

The verified market snapshot reports 19.93%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 27, 2026.

Get free Kyverna Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Debt-to-equity ratio
19.93%